Does tranexamic acid reduce bleeding during brain tumor surgery?
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether a medication called tranexamic acid (TXA) given during brain tumor surgery can reduce bleeding. If you are having a standard craniotomy for a tumor and don’t have certain health risks, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled to have a craniotomy (a surgical opening of the skull) to remove a brain tumor.
- You do not have a history of blood clots or a clotting disorder.
- You do not have a bleeding disorder (like hemophilia) or severe kidney disease.
- You are not pregnant, breastfeeding, or have Class 3 obesity (BMI ≥ 40).
- Your surgery is not an emergency or a mini-craniotomy, and you haven't had embolization before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.